Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
454.64
-5.61 (-1.22%)
Nov 16, 2026, 10:47 AM EST - Market open
Waters Employees
Waters had 7,900 employees as of December 31, 2025. The number of employees increased by 300 or 3.95% compared to the previous year. That makes Waters the 4,025th largest employer in the world and 894th in the United States.
Employees
7,900
Change (1Y)
300
Growth (1Y)
3.95%
Revenue / Employee
$710,163
Profits / Employee
$12,485
Market Cap
44.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,900 | 300 | 3.95% |
| Dec 31, 2024 | 7,600 | -300 | -3.80% |
| Dec 31, 2023 | 7,900 | -300 | -3.66% |
| Dec 31, 2022 | 8,200 | 400 | 5.13% |
| Dec 31, 2021 | 7,800 | 400 | 5.41% |
| Dec 31, 2020 | 7,400 | -100 | -1.33% |
| Dec 31, 2019 | 7,500 | 300 | 4.17% |
| Dec 31, 2018 | 7,200 | 200 | 2.86% |
| Dec 31, 2017 | 7,000 | 100 | 1.45% |
| Dec 31, 2016 | 6,900 | 300 | 4.55% |
| Dec 31, 2015 | 6,600 | 400 | 6.45% |
| Dec 31, 2014 | 6,200 | 200 | 3.33% |
| Dec 31, 2013 | 6,000 | 100 | 1.69% |
| Dec 31, 2012 | 5,900 | 200 | 3.51% |
| Dec 31, 2011 | 5,700 | 300 | 5.56% |
| Dec 31, 2010 | 5,400 | 200 | 3.85% |
| Dec 31, 2009 | 5,200 | 200 | 4.00% |
| Dec 31, 2008 | 5,000 | 0 | - |
| Dec 31, 2007 | 5,000 | 300 | 6.38% |
| Dec 31, 2006 | 4,700 | 200 | 4.44% |
| Dec 31, 2005 | 4,500 | 300 | 7.14% |
| Dec 31, 2004 | 4,200 | 300 | 7.69% |
| Dec 31, 2003 | 3,900 | 300 | 8.33% |
| Dec 31, 2002 | 3,600 | 100 | 2.86% |
| Dec 31, 2001 | 3,500 | 300 | 9.38% |
| Dec 31, 2000 | 3,200 | 200 | 6.67% |
| Dec 31, 1999 | 3,000 | 200 | 7.14% |
| Dec 31, 1998 | 2,800 | 160 | 6.06% |
| Dec 31, 1997 | 2,640 | 550 | 26.32% |
| Dec 31, 1996 | 2,090 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 95,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,200 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
| Illumina | 10,080 |
WAT News
- 5 days ago - Waters announces FDA 510(k) clearance of ready-to-use flow cytometry tests - TheFly
- 6 days ago - Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma - PRNewsWire
- 11 days ago - Waters price target raised to $530 from $480 at Piper Sandler - TheFly
- 12 days ago - Waters price target raised to $530 from $515 at TD Cowen - TheFly
- 12 days ago - Waters price target raised to $525 from $475 at RBC Capital - TheFly
- 12 days ago - Waters price target raised to $500 from $460 at KeyBanc - TheFly
- 12 days ago - Waters price target raised to $470 from $435 at JPMorgan - TheFly
- 12 days ago - Waters price target raised to $536 from $470 at Citi - TheFly